By: T.D. Thornton Thoroughbreds racing in California will no longer be allowed to race with any detectable level of the bronchodilator medication clenbuterol in their systems, effective Nov. 15. The change is a result of evidence the California Horse Racing Board (CHRB) has collected via out-of-competition testing (OOC), and the measure was passed unanimously Thursday
By: Dan Ross Using the information fed into the Jockey Club’s Equine Injury Database (EID) concerning race-day equine fatalities, the numbers nationwide appear to have declined over the past few years, from a rate of two every 1000 starters back in 2009, to a little over 1.5 in 2016. The latest EID figures for 2017
By: Daniel Ross Like all drugs, bisphosphonates are a proven fillip when administered to treat specific conditions in accordance with official guidelines. But like all drugs, bisphosphonates can be misused and abused. And it’s the potential consequences from misuse in racehorses — especially in young racehorses — that’s causing mounting concern among a growing number
By: Jeremy Balan Los Pollos Hermanos Racing and Jay Em Ess Stable's Masochistic was not allowed to enter the Dec. 31 Midnight Lute Stakes (gr. III) at Santa Anita Park because he lacks a clean drug test following his positive post-race test for stanozolol after the Nov. 5 TwinSpires Breeders' Cup Sprint (gr. I). California
By: Frank Angst Breeders' Cup officials are calling for improved out-of-competition rules and protocols after a positive post-race drug test for the anabolic steroid stanozolol in Masochistic will result in a disqualification of his runner-up finish in the  $1.5 million TwinSpires Breeders' Cup Sprint (gr. I) Nov. 5 at Santa Anita Park. Breeders Cup expressed disappointment
By: Jeremy Balan The California Horse Racing Board's Medication, Safety, and Welfare Committee Dec. 14 moved forward three measures to adjust training regulations more into line with rules currently employed for racing. During the committee meeting Wednesday at Los Alamitos Race Course, CHRB members Madeline Auerbach and Alex Solis, along with CHRB executive director Rick
By: Jay Hovdey Let’s concede for a moment that some people will cheat to win. I know, it’s hard to swallow. But human nature, being driven by human beings, sometimes veers toward the dark side, and it is up to those who prefer to play the game on the square to make cheating a no-win
By: Frank Angst The California Horse Racing Board will again consider adopting a third-party Lasix administration policy at its regular meeting June 16. The rule on third-party Lasix administration on race day is on the agenda for the June 16 CHRB meeting, confirms spokesman Mike Marten. The rule would meet the standards of the Association of Racing
By: Frank Angst Racing Medication and Testing Consortium executive director Dionne Benson said as regulators look at new, enhanced recommendations on out-of-competition testing, they're going to find policies that will work for the industry. Participating on an equine welfare and veterinary panel March 23 at the RCI conference in New Orleans, Benson is encouraged that
By Jeremy Balan The California Horse Racing Board Medication and Track Safety Committee took a step forward Sept. 4 regarding the potential employment of third-party furosemide administration in the state, but any change in procedures still likely won't occur until 2016. After the CHRB sent a proposal on third-party administration of furosemide, commonly known as
SIGN UP TO RECEIVE RMTC COMMUNICATIONS
Quick Links
Sign up to receive RMTC communications:
Sign up to receive RMTC communications:
